Author

N. Kops

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:multiple species· 1 Approach:statistical model· 1

Frequent Co-Authors

G. J. V. M. van Osch· 2 shared A. A. Pitsillides· 1 shared A. Chavli· 1 shared B. van Rietbergen· 1 shared E. Farrell· 1 shared F. T. Bekedam· 1 shared G. Filardo· 1 shared J. Kok· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

G. J. V. M. van Osch

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Incorporating strontium enriched amorphous calcium phosphate granules in collagen/collagen-magnesium-hydroxyapatite osteochondral scaffold improves subchondral bone repair

J. Xu, J. Vecstaudza, M. A. Wesdorp, M. Labberte, N. Kops, M. Salerno, J. Kok, M. Simon, M.-F. Harmand, K. Vancikova, B. van Rietbergen, M. M. Misciagna, L. Dolcini, G. Filardo, E. Farrell, , P. A. J. Brama

This study shows that adding strontium-enriched amorphous calcium phosphate granules to a collagen scaffold improves subchondral bone repair in a goat model.

bioRxiv · Jun 15, 2023Bioengineering

In silico, in vitro, and in vivo models reveal EPHA2 as a target for decreasing inflammation and pathological endochondral ossification in osteoarthritis.

M. N. Ferrao Blanco, R. Lesage, N. Kops, N. Fahy, F. T. Bekedam, A. Chavli, Y. M. Bastiaansen-Jenniskens, L. Geris, M. G. Chambers, A. A. Pitsillides, R. Narcisi, G. J. V. M. van Osch

This study identifies EPHA2 as a therapeutic target for osteoarthritis by showing its inhibition reduces inflammation and pathological endochondral ossification in both in vitro and in vivo models.

bioRxiv · Jun 12, 2022Pharmacology & Toxicology